Trifecta Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$367 Buy
+4
New +$350 ﹤0.01% 435
2025
Q4
Sell
-18
Closed -$1.44K 295
2025
Q3
$1.44K Sell
18
-43
-70% -$3.67K ﹤0.01% 378
2025
Q2
$5.54K Buy
61
+43
+239% +$3.93K ﹤0.01% 263
2025
Q1
$1.69K Hold
18
﹤0.01% 328
2024
Q4
$1.64K Hold
18
﹤0.01% 324
2024
Q3
$1.87K Sell
18
-190
-91% -$19.4K ﹤0.01% 318
2024
Q2
$20.2K Buy
208
+190
+1,056% +$17.5K ﹤0.01% 190
2024
Q1
$1.62K Hold
18
﹤0.01% 327
2023
Q4
$1.44K Hold
18
﹤0.01% 358
2023
Q3
$1.28K Hold
18
﹤0.01% 352
2023
Q2
$1.39K Hold
18
﹤0.01% 345
2023
Q1
$1.35K Hold
18
﹤0.01% 346
2022
Q4
$1.42K Buy
+18
New +$1.35K ﹤0.01% 348

Other funds holding CL

Trifecta Capital Advisors's CL Position: Q2 2026 in Review

Trifecta Capital Advisors opened a new position in Colgate-Palmolive (CL) in Q2 2026: 4 shares worth $367. The stake represents ﹤0.01% of the portfolio and ranks #435 among its holdings. This is a return to the name: Trifecta Capital Advisors previously reported a position in CL as recently as Q3 2025.

Trifecta Capital Advisors first reported a position in CL in Q4 2022 and has held it in 13 quarters since. The position peaked at $20.2K in Q2 2024. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Trifecta Capital Advisors held 4 shares of Colgate-Palmolive worth $367 as of Q2 2026.
  • Colgate-Palmolive was a new Trifecta Capital Advisors position in Q2 2026.
  • Colgate-Palmolive made up ﹤0.01% of Trifecta Capital Advisors's portfolio in Q2 2026, its #435 holding.
  • Trifecta Capital Advisors first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 13 quarters since.
  • Trifecta Capital Advisors's Colgate-Palmolive position peaked at $20.2K in Q2 2024.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Trifecta Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.